TEAH DEWITT: Open Payments
NPI 1245092352 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,846 in 133 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $2,846
Food & beverage: $2,803Education: $43
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $398 |
| Regeneron Healthcare Solutions, Inc. | 10 | $389 |
| GENZYME CORPORATION | 8 | $326 |
| Novartis Pharmaceuticals Corporation | 19 | $320 |
| ABBVIE INC. | 23 | $284 |
| PFIZER INC. | 8 | $214 |
| UCB, Inc. | 6 | $174 |
| Galderma Laboratories, L.P. | 23 | $162 |
| Amgen Inc. | 4 | $160 |
| Arcutis Biotherapeutics, Inc. | 5 | $109 |
Products named: DUPIXENT, TREMFYA, RINVOQ, COSENTYX, Bimzelx, OTEZLA, NEMLUVIO, LITFULO.
Industry payments across AL — which companies pay providers there.
